Dr Mark Bowman MBA, CEO PulmonIR
Dr Mark Bowman has enjoyed a diverse career spanning academic research, technology transfer and seed stage venture capital investment.
In 2016, he co-founded PulmonIR Ltd focused on the diagnosis and monitoring of lung disease. As CEO, Mark has secured substantial venture capital investment as well as public sector innovation grants.
Mark founded his consultancy business Arche Innovations Ltd in 2012. The company’s assignments include assisting the GE Healthcare Innovation Village launch, directing the investment readiness programme InvestorG8, and helping to establish Swansea University’s venture capital co-investment fund (SUIF). The company was recently appointed as Pipeline Manager for the AgorIP project